Folate (Active 5-MTHF)
5-MTHF (L-methylfolate) is the active, pre-methylated form of folate that crosses the blood-brain barrier directly. Critical for people with MTHFR gene variants (present in ~40% of population) who cannot efficiently convert folic acid. More effective than folic acid for neurological function and homocysteine reduction.
How it works (mechanism of action)
Directly usable by all cells without conversion. Crosses blood-brain barrier for CNS methylation reactions. Reduces homocysteine via methionine synthase without the conversion steps required by folic acid or standard folate.
Evidence grades: A=Strong RCT evidence · B=Good clinical trials · C=Limited trials · D=Preliminary/traditional
Very safe. Masking B12 deficiency (same concern as standard folate). MTHFR variants: check genotype before assuming standard folate is adequate. Methotrexate (chemotherapy) is a folate antagonist — DO NOT combine without oncologist guidance.
- Pratte MA, et al. J Altern Complement Med. 2014;20(12):901-8. SR/Meta-analysis PubMed ↗
Evidence grades: SR = Systematic review / meta-analysis (highest) · RCT = Randomized controlled trial · Reg = Regulatory/official guidance
